주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
121 )
기사목록 보기 형태
제목형
요약형
포토형
MSD Korea expands ERP targets by raising consolatory payment
Kim Yun-mi
2023.07.17 16:48
Sanofi’s cold agglutinin disease treatment Enjaymo lands in Korea
Kim Yun-mi
2023.07.13 16:00
Exkivity's clinical value noted in treating rare EGFR exon 20 insertion mutation in NSCLC
Kim Yun-mi
2023.07.13 14:31
Severe asthma treatment Cinqair passes drug review 6 years after approval
Kim Yun-mi
2023.07.07 15:55
‘Asthma care in Korea reminds me of Canada 8 years ago’
Kim Yun-mi
2023.07.03 11:48
AstraZeneca to release highly concentrated formulation of orphan drug Ultomiris
Kim Yun-mi
2023.06.30 14:44
Novartis’ Scemblix gets benefit to treat chronic myeloid leukemia 3rd or more times
Kim Yun-mi
2023.06.30 11:25
Diabetes drug Mounjaro landed here. But can Koreans use it?
Kim Yun-mi
2023.06.29 17:06
MSD seeks reimbursement for 13 Keytruda indications, including endometrial cancer
Kim Yun-mi
2023.06.28 11:11
Experts from 9 Asia-Pacific countries join forces to fight heart disease
Kim Yun-mi
2023.06.26 16:18
Enhertu recognized in Asia, too, as essential targeted agent for breast cancer
Kim Yun-mi
2023.06.26 15:52
AstraZeneca’s Imjudo gets regulatory nod as 1st-line liver cancer treatment
Kim Yun-mi
2023.06.23 15:45
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기